New Cancer Info Made Easy
A fast and easy way to find out about all new FDA approved cancer treatments.
Thursday, June 12, 2014
Zykadia for ALK+ tumors
Zykadia (ceritinib) is now approved for the treatment of metastatic ALK+ non-small cell lung cancer if there has been disease progression on crizotinib or the patient is intolerant to crizotinib.
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)